Molecular characterization and susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from hospitals and the community in Vladivostok, Russia

Clinical Microbiology and Infection

Volumn 16, Issue 6, 2010, Pages 575-582

  Baranovich, T ^a   Zaraket, H ^a   Shabana, I I ^a   Nevzorova, V ^b   Turcutyuicov, V ^b   Suzuki, H ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b PACIFIC STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antimicrobial susceptibility; Community acquired; Hospital acquired; Molecular typing; Russia; Staphylococcus aureus

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFACLOR; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MINOCYCLINE; NORFLOXACIN; OXACILLIN; PANTON VALENTINE LEUKOCIDIN; PENICILLIN G; RIFAMPICIN; STAPHYLOCOCCUS PROTEIN A; SULFAMETHOXAZOLE; TEICOPLANIN; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CHILD; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RUSSIAN FEDERATION; SEQUENCE ANALYSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS AUREUS;

EID: 77953928069     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02891.x     Document Type: Article

References (28)

1. Lowy F. Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 2003, 111:1265-1273.
2. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485. National Nosocomial Infections Surveillance System
3. Oliveira D, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002, 2:180-189.
4. Tristan A, Bes M, Meugnier H. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007, 13:594-600.
5. Lina G, Piémont Y, Godail-Gamot F. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
6. Melles D, Gorkink R, Boelens H. Natural population dynamics and expansion of pathogenic clones of Staphylococcus aureus. J Clin Invest 2004, 114:1732-1740.
7. Stratchounski L, Dekhnich A, Kretchikov V. Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russia: results of a prospective study. J Chemother 2005, 17:54-60.
8. Nathwani D, Morgan M, Masterton R. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008, 61:976-994.
9. Murray P, Baron E, Jorgensen J. Manual of clinical microbiology 2003, 8th edn, Washington, DC, American Society for Microbiology
10. Murchan S, Kaufmann M, Deplano A. Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol 2003, 41:1574-1585.
11. Gilot P, Lina G, Cochard T, Poutrel B. Analysis of the genetic variability of genes encoding the RNA III-activating components agr and trap in a population of Staphylococcus aureus strains isolated from cows with mastitis. J Clin Microbiol 2002, 40:4060-4067.
12. Oliveira D, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002, 46:2155-2161.
13. Hisata K, Kuwahara-Arai K, Yamanoto M. Dissemination of methicillin-resistant staphylococci among healthy Japanese children. J Clin Microbiol 2005, 43:3364-3372.
14. Koreen L, Ramaswamy S, Graviss E, Naidich S, Musser J, Kreiswirth B. Spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation. J Clin Microbiol 2004, 42:792-799.
15. Enright M, Day N, Davies C, Peacock S, Spratt B. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
16. Diep B, Carleton H, Chang R, Sensabaugh G, Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006, 193:1495-1503.
17. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement. M100-s18 2008, Clinical and Laboratory Standards Institute, Wayne, PA, CLSI
18. Comité de l'antibiogramme de la société française de microbiologie report 2003. Int J Antimicrob Agents 2003, 21:364-391. Members of the SFM Antibiogram Committee
19. Finlay J, Miller L, Poupard J. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997, 41:1137-1139.
20. Trzcinski K, Cooper B, Hryniewicz W, Dowson C. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2000, 45:763-770.
21. Choi S, Kim S, Kim H. Multiplex PCR for the detection of genes encoding aminoglycoside modifying enzymes and methicillin resistance among Staphylococcus species. J Korean Med Sci 2003, 18:631-636.
22. Otsuka T, Zaraket H, Takano T. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan. Clin Microbiol Infect 2007, 13:325-327.
23. Aubry-Damon H, Soussy C, Courvalin P. Characterization of mutations in the rpob gene that confer rifampin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1998, 42:2590-2594.
24. Amaral M, Coelho L, Flores R. The predominant variant of the Brazilian epidemic clonal complex of methicillin-resistant Staphylococcus aureus has an enhanced ability to produce biofilm and to adhere to and invade airway epithelial cells. J Infect Dis 2005, 192:801-810.
25. Strachunskii L, Kozlov S. An update on antimicrobial chemotherapy: the clinician's guide 2002, 121-123. Moscow, Borges
26. Dauwalder O, Lina G, Durand G. Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008, 46:3454-3458.
27. Labandeira-Rey M, Couzon F, Boisset S. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
28. Bubeck Wardenburg J, Bae T, Otto M, Deleo F, Schneewind O. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007, 13:1405-1406.